identifying positive regulators of t cell functions to improve cellular therapies
Published 2 years ago • 90 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
2:41
cell avidity as a predictor of t-cell efficacy
-
2:49
identifying novel antigens for tcr t-cell therapy
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
1:02
expanding the clinical applications of avidcar t-cells
-
1:03
measuring cell avidity to assess the efficacy of t-cell therapies
-
1:39
the role of myeloid cells in car-t cell therapy
-
3:30
targeting t-cell, b-cell & apc activation to treat chronic gvhd
-
2:48
virus-specific t cells - effectiveness, safety profile and use
-
2:10
driving the identification of novel t cell therapies
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:02
the use of car-t cell products in a real-world setting
-
1:52
single-cell and immune sequencing to predict response and resistance to car-t therapy in r/r mm
-
1:14
'off the shelf' virus-specific t cells
-
1:45
evaluating nivolumab-based therapy to restore t-cell fitness in patients with r/r multiple myeloma
-
2:18
redirecting t-cell cytotoxicity and proliferation
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
2:20
ebmt diagnostic criteria for tma post-allosct and the role of complement activation
-
3:01
t-cell engaging antibodies: novel combinations to overcome resistance
-
1:24
t-cell engaging antibodies: what lessons have we learnt?